What's new

Human medicines European public assessment report (EPAR): Voydeya, Danicopan, Date of authorisation: 19/04/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Voydeya, Danicopan, Date of authorisation: 19/04/2024, Revision: 1, Status: Authorised

Feb 27, 2025 - 10:12
 0
Human medicines European public assessment report (EPAR): Voydeya, Danicopan, Date of authorisation: 19/04/2024, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Voydeya, Danicopan, Date of authorisation: 19/04/2024, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

Nio’s battery swap operation could break even in 2026

Next Article

Wyse London appoints new CEO

Related Posts

Human medicines European public assessment report (EPAR): Lenvima, lenvatinib, Date of authorisation: 28/05/2015, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 20, 2025  0

EMEA-003466-PIP01-23

EMEA-003466-PIP01-23

Mar 7, 2025  0

Summary of opinion: Ixchiq, 27/02/2025 Positive

Summary of opinion: Ixchiq, 27/02/2025 Positive

Feb 28, 2025  0